Statistically significant lower risk is seen for viral clearance. 3 studies from 2 independent teams (all from the same country) show significant improvements.
Meta analysis using the most serious outcome reported shows 26% [-14‑52%] lower risk, without reaching statistical significance. Results are worse for peer-reviewed studies. Currently all studies are RCTs.
Currently there is limited data, with only 1 control event for the most serious outcome in trials to date. Studies to date are from only 2 different groups.
No treatment or intervention is 100% effective. All practical, effective, and safe means should be used based on risk/benefit analysis. Multiple treatments are typically used in combination, and other treatments are more effective.
All data to reproduce this paper and sources are in the appendix.
Covid Analysis et al., May 2024, preprint, 1 author.